AI Applications for Drug Discovery and Development is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Savan Devani Founder and CEO at Biotrillion

Profile

Savan Devani is the Founder and CEO of BioTrillion, a health technology company developing a platform called BioEngine4D to digitally detect developing diseases.

Savan previously spent the majority of his 15-year career as a healthcare investment banker with Citigroup and Deutsche Bank. From Analyst through Managing Director, Savan completed 40 financing and M&A deals, totaling $35 billion in deal value, with clients across the drug, diagnostic, and device spectrum. He began his career as a bioengineer at Life Technologies.

Savan graduated with a B.S.E. in Bioengineering from the University of California at Berkeley and a M.S.E. in Bioengineering from the University of Pennsylvania.

Agenda Sessions